Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/32020
Title: ANGIOTENSIN III MODULATES the NOCICEPTIVE CONTROL MEDIATED BY the PERIAQUEDUCTAL GRAY MATTER
Authors: Pelegrini-da-Silva, A.
Rosa, E.
Guethe, L. M.
Juliano, M. A. [UNIFESP]
Prado, W. A.
Martins, A. R.
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Keywords: antinociception
tail flick and allodynia models
renin-angiotensin system
Losartan
CGP 42
112A
divalinal-angiotensin IV
Issue Date: 15-Dec-2009
Publisher: Elsevier B.V.
Citation: Neuroscience. Oxford: Pergamon-Elsevier B.V., v. 164, n. 3, p. 1263-1273, 2009.
Abstract: Endogenous angiotensin (Ang) II and/or an Ang II-derived peptide, acting on Ang type I (AT(1)) and Ang type 2 (AT(2)) receptors, can carry out part of the nociceptive control modulated by periaqueductal gray matter (PAG). However, neither the identity of this putative Ang-peptide, nor its relationship to Ang II antinociceptive activity was clarified. Therefore, we have used tail-flick and incision allodynia models combined with an HPLC time course of Ang metabolism, to study the Ang III antinociceptive effect in the rat ventrolateral (vi) PAG using peptidase inhibitors and receptor antagonists. Ang III injection into the vIPAG increased tail-flick latency, which was fully blocked by Losartan and CGP 42,112A, but not by divalinal-Ang IV, indicating that. Ang III effect was mediated by AT(1) and AT(2) receptors, but not by the AT(4) receptor. Ang III injected into the vIPAG reduced incision allodynia. Incubation of Ang II with punches of vIPAG homogenate formed Ang III, Ang (1-7) and Ang IV. Amastatin (AM) inhibited the formation of Ang III from Ang II by homogenate, and blocked the antinociceptive activity of Ang II injection into vIPAG, suggesting that aminopeptidase A (APA) formed Ang III from Ang II. Ang III can also be formed from Ang I by a vIPAG alternative pathway. Therefore, the present work shows, for the first time, that: (i) Ang III, acting on AT(1) and AT(2) receptors, can elicit vIPAG-mediated antinociception, (ii) the conversion of Ang II to Ang III in the vIPAG is required to elicit antinociception, and (iii) the antinociceptive activity of endogenous Ang II in vIPAG can be ascribed preponderantly to Ang III. (C) 2009 IBRO. Published by Elsevier B.V. All rights reserved.
URI: http://repositorio.unifesp.br/handle/11600/32020
ISSN: 0306-4522
Other Identifiers: http://dx.doi.org/10.1016/j.neuroscience.2009.09.004
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.